AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 111 min read$CRD-A

CRAWFORD JESSE C sold $12.8M of CRD-A

CRAWFORD JESSE C sold 1,000,000 shares of CRAWFORD & CO (CRD-A) at $12.81 ($12.81M total) on 2026-08-10.

Original reporting
SEC EDGAR · CRAWFORD JESSE C
Published Aug 11, 2026, 8:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CRD-A
Neutral
low confidence
Mentioned
$CRD-A
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CRD-ANeutralLow
01

Why it matters

A disclosed open-market sale by a 10% owner may slightly pressure sentiment, but the filing alone does not provide new operational, financial, or regulatory information.

02

Market read

Traders may monitor CRD-A for follow-on insider activity, but the text contains no fundamental catalyst.

03

What to watch

The article does not state whether other insiders sold/bought, whether the sale was part of a broader pattern, or whether there were concurrent company disclosures.

Relevance 7/10Novelty 3/10Timing: filed 2026-08-11 after-hours; sale dated 2026-08-10

Background

The article is an SEC Form 4 insider transaction disclosure for Crawford & Co (CRD-A).

Company-level read

Ticker impact

$CRD-ANeutralLow confidence
Context

Form 4 shows 10% owner Jesse C Crawford sold 1,000,000 shares of CRD-A at $12.8137 on 2026-08-10.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and typically fades unless accompanied by other news.

Evidence & confidence

This is a routine Form 4 transaction with no 10b5-1 plan stated and no accompanying company-specific catalyst in the text.

Market effects

Sector

No sector read-through provided; this is company-specific insider trading disclosure.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale could be for diversification or liquidity needs rather than a bearish view, especially since no 10b5-1 plan is cited in the text.

Key entities

  • issuer
    CRAWFORD & CO

    Company whose shares (CRD-A) are subject of the Form 4 insider sale.

  • insider
    Jesse C Crawford

    10% owner who sold 1,000,000 shares at $12.8137 on 2026-08-10.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CRD-A insider trading history →

Related articles

NOV 2
$CRD-AMedAI 8/10

Crawford & Company Reports 2026 Third Quarter Results

Crawford & Company (CRD-A, CRD-B) reported Q3 2026 revenues of $321.6M, down slightly from $322.2M in Q3 2025. Net income rose to $15.0M ($0.31 per share) from $12.4M ($0.25 per share). International operations drove improved performance, while U.S. segments saw declines. The CEO highlighted progress in cost management and client relationships, but expects fourth-quarter pressure from lower claims frequency.

saultstar.com6 min
AUG 3
$CRD-AMed

CRAWFORD & COMPANY REPORTS 2026 SECOND QUARTER RESULTS

CRAWFORD & CO (CRD-A) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Crawford & Company® 5335 Triangle Parkway Peachtree Corners, GA 30092 FOR IMMEDIATE RELEASE CRAWFORD & COMPANY REPORTS 2026 SECOND QUARTER RESULTS Strong Earnings Growth Driven by International Operations and Broadspire Quarterly Dividend Increases to $0.08 per Share

SEC EDGAR 8-K6 min
NOV 3
$ASPEMedAI 8/10

ARCH Venture Fund X, L.P. (CRANDELL KEITH, Burow Kristina) purchased $18.0M of ASPE (indirect holdings)

ARCH Venture Fund X, L.P. purchased 1,200,000 indirectly-held shares of Aspen Neuroscience, Inc. (ASPE) at $15.00 ($18.00M total) on 2026-11-02. Filed jointly with ARCH Venture Fund X Overage, L.P. (10% owner), ARCH Venture Partners X, L.P. (10% owner), ARCH Venture Partners X Overage, L.P. (10% owner), ARCH Venture Partners X, LLC (10% owner), CRANDELL KEITH (10% owner), Burow Kristina (10% owner), GILLIS STEVEN (10% owner) and NELSEN ROBERT (10% owner).

SEC EDGAR1 min
NOV 3
$ASPELow

ARCH Venture Fund X, L.P. (CRANDELL KEITH, Burow Kristina) purchased $2.0M of ASPE

ARCH Venture Fund X, L.P. purchased 133,333 shares of Aspen Neuroscience, Inc. (ASPE) at $15.00 ($2.00M total) across 2 trades on 2026-11-02. Filed jointly with ARCH Venture Fund X Overage, L.P. (10% owner), ARCH Venture Partners X, L.P. (10% owner), ARCH Venture Partners X Overage, L.P. (10% owner), ARCH Venture Partners X, LLC (10% owner), CRANDELL KEITH (10% owner), Burow Kristina (10% owner), GILLIS STEVEN (10% owner) and NELSEN ROBERT (10% owner).

SEC EDGAR1 min